Determination of Clopidogrel in Pharmaceutical Preparation by UV Spectrophotometry and High Performance Liquid Chromatography Methods

Year 2020, Volume: 4 Issue: 1, 14 - 19, 15.07.2020

Ömer Faruk Koçak Yücel Kadıoğlu Onur Şenol

Abstract

UV-Visible spectroscopy and high performance liquid chromatography (HPLC) methods were developed and validated for determination of clopidogrel in bulk and pharmaceutical formulations. In spectroscopy, clopidogrel spectrum at different solutions was taken and the best absorbance value was obtained at 202 nm wavelength in methanol-acetonitrile (50:50.h/h) mixture. In HPLC, parameters were optimized as follows: mobile phase was acetonitrile-methanol-water (45:45:10, v/v/v), C18 re-serve phase column was preferred, flow rate and injection volume were set as 0.9 mL/min and 10 μL, respectively. All measurements were performed at 230 nm wavelength. Meloxicam was used as an internal standard in HPLC. Linearity, analytic recovery, intra and inter-days precision and accuracy were investigated in order to per-form validation process, It was stated that HPLC measurements were linear at 0.25-30 μg/mL while UV-Visible method linear at 1.25-25 μg/mL. Intra and inter-days precision and accuracy values were 5.38% and 2.66% for HPLC method and 3.77% and 3.60% for UV-Vis. Mean analytic recovery value was found to be 99.5% for both methods. Developed and validated HPLC and UV-Vis methods were applied to pharmaceutical preparations including clopidogrel.

Keywords

Clopidogrel, UV-Visible spectrophotometry, HPLC

References

• Yucel Y. Migraine Headache: Diagnostic and management approache. Dicle Med J (2008) 35(4):281–286.
• Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. The Lancet Neurology (2018) 17(1):75–83.
• Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia (2018) 38(1):1–211.
• Weatherall MW. Drug therapy in headache. Clinical Medicine (2015) 15(3):273.
• Ozkurt B, Cinar O, Cevik E, Acar AY, Arslan D, Eyi EY, et al. Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial. The American journal of emergency medicine (2012) 30(9):1760–1764.
• O’Brien M, Ford JH, Aurora SK, Govindan S, Tepper DE, Tepper SJ. Economics of inhaled oxygen use as an acute therapy for cluster headache in the United States of America. Headache: The Journal of Head and Face Pain (2017) 57(9):1416–1427.
• Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology (2006) 67(1):109–113.
• Mayans L, Walling A. Acute migraine headache: treatment strategies. American family physician (2018) 97(4):243–251.
• Long BJ, Koyfman A. Benign headache management in the emergency department. The Journal of emergency medicine (2018) 54(4):458–468.
• Diener H-C, Holle D, Dresler T, Gaul C. Chronic headache due to overuse of analgesics and anti-migraine agents. Deutsches Ärzteblatt International (2018) 115(22):365.
• Markman J, Meske DS, Kopecky EA, Vaughn B, O’Connor ML, Passik SD. Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone. Journal of pain research (2018) 11:2051.
• Friedman BW, West J, Vinson DR, Minen MT, Restivo A, Gallagher EJ. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey. Cephalalgia (2015) 35(4):301–309.
• Loder E, Weizenbaum E, Frishberg B, Silberstein S, Force, American Headache Society Choosing Wisely Task. Choosing Wisely in Headache Medicine: The A merican Headache Society’s List of Five Things Physicians and Patients Should Question. Headache: The Journal of Head and Face Pain (2013) 53(10):1651–1659.
• Tyrrell EG, Kendrick D, Sayal K, Orton E. Poisoning substances taken by young people: a population-based cohort study. Br J Gen Pract (2018) 68(675):e703-e710.
• Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Archives of toxicology (2015) 89(2):193–199.
• Ruzek M, Richman P, Eskin B, Allegra JR. ED treatment of migraine patients has changed. The American journal of emergency medicine (2019) 37(6):1069–1072.
• Meyering SH, Stringer RW, Hysell MK. Randomized trial of adding parenteral acetaminophen to prochlorperazine and diphenhydramine to Idiman F. Headache Diagnosis and Treatment Current Approaches. 1 edn. Istanbul: Turkish Neurology Society Publication. In: Bıcakcı S, Ozturk M, Ucler S, Karlı N, Siva A, editors. Headaches last forty years (2018). p. 9–22.
• Idıman F. Migraine headache, types, diagnosis and treatment. J Neurol-Special Topics (2018) 11(1):28–42.
• Najjar M, Hall T, Estupinan B. Metoclopramide for acute migraine treatment in the emergency department: an effective alternative to opioids. Cureus (2017) 9(4).
• Friedman BW, Mulvey L, Esses D, Solorzano C, Paternoster J, Lipton RB, et al. Metoclopramide for acute migraine: a dose-finding randomized clinical trial. Annals of emergency medicine (2011) 57(5):475-482. e1.
• Naeem F, Schramm C, Friedman BW. Emergent management of primary headache: a review of current literature. Current opinion in neurology (2018) 31(3):286–290.
• Tepper SJ, Duplin J, Nye B, Tepper DE. Prescribing oxygen for cluster headache: A guide for the provider. Headache: The Journal of Head and Face Pain (2017) 57(9):1428–1430.
• Orr SL, Aube M, Becker WJ, Davenport WJ, Dilli E, Dodick D, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia (2015) 35(3):271–284.
• Jones CW, Gaughan JP, McLean SA. Epidemiology of intravenous fluid use for headache treatment: Findings from the National Hospital Ambulatory Medical Care Survey. The American journal of emergency medicine (2017) 35(5):778–781.